Elkfork Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$8.37M Buy
77,022
+16,874
+28% +$1.76M 0.2% 97
2019
Q2
$5.86M Buy
60,148
+20,988
+54% +$1.92M 0.14% 139
2019
Q1
$3.57M Buy
39,160
+13,640
+53% +$1.22M 0.09% 192
2018
Q4
$2.32M Sell
25,520
-5,852
-19% -$547K 0.07% 236
2018
Q3
$3.09M Sell
31,372
-726
-2% -$67.1K 0.07% 225
2018
Q2
$2.75M Buy
32,098
+6,490
+25% +$542K 0.07% 229
2018
Q1
$2.05M Buy
25,608
+330
+1% +$27.2K 0.06% 232
2017
Q4
$2.04M Buy
25,278
+8,382
+50% +$671K 0.06% 248
2017
Q3
$1.31M Sell
16,896
-1,782
-10% -$148K 0.04% 289
2017
Q2
$1.66M Sell
18,678
-308
-2% -$26K 0.05% 255
2017
Q1
$1.53M Buy
18,986
+5,236
+38% +$409K 0.05% 273
2016
Q4
$979K Buy
+13,750
New +$1.08M 0.03% 305

Other funds holding MDT

Elkfork Partners's MDT Position: Q3 2019 in Review

Elkfork Partners increased its Medtronic (MDT) stake by 28% in Q3 2019, buying an estimated $1.76M and bringing the position to 77,022 shares worth $8.37M. The position accounts for 0.2% of the portfolio, ranked #97.

Elkfork Partners first reported a position in MDT in Q4 2016 and has held it in 12 quarters since. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Elkfork Partners held 77,022 shares of Medtronic worth $8.37M as of Q3 2019.
  • Elkfork Partners bought 16,874 Medtronic shares in Q3 2019, an estimated $1.76M.
  • Medtronic made up 0.2% of Elkfork Partners's portfolio in Q3 2019, its #97 holding.
  • Elkfork Partners first reported a position in Medtronic in Q4 2016 and has held it in 12 quarters since.
  • 1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.